HOME >> BIOLOGY >> NEWS
Genetic roots of bipolar disorder revealed by first genome-wide study of illness

The likelihood of developing bipolar disorder depends in part on the combined, small effects of variations in many different genes in the brain, none of which is powerful enough to cause the disease by itself, a new study shows. However, targeting the enzyme produced by one of these genes could lead to development of new, more effective medications. The research was conducted by scientists at the National Institutes of Health's National Institute of Mental Health (NIMH), with others from the Universities of Heidelberg and Bonn and a number of U.S. facilities collaborating in a major project called the NIMH Genetics Initiative.

The study is the first to scan virtually all of the variations in human genes to find those associated with bipolar disorder. Results were published online May 8 in Molecular Psychiatry by Amber E. Baum, PhD, lead researcher Francis J. McMahon, MD, and colleagues.

"This is an example of how advances in genetics research feed into practical applications. This research would not have been possible a very few years ago. We now have a new molecular target scientists can investigate in their search for better medications for bipolar disorder," said NIH Director Elias A. Zerhouni, MD.

About 5.7 million American adults have bipolar disorder, which also is called manic-depressive illness. Symptoms include extremes in mood, from pronounced over-excitement and elation, often coupled with severe irritability, to depression. Children also may have the condition, usually in a more severe form than adults.

"We're beginning to get a foothold on the genetics of this complex brain disorder," said NIMH Director Thomas R. Insel, MD.

Most people occasionally have mood swings, but the shifts that occur in bipolar disorder, and the changes in behavior and energy level that accompany them, are sometimes disabling. Lithium and the other mood-stabilizing medications used to treat the condition help many pati
'"/>

Contact: Susan Cahill
scahill@mail.nih.gov
301-443-4536
NIH/National Institute of Mental Health
8-May-2007


Page: 1 2 3

Related biology news :

1. Genetic variation helps to understand predisposition to schizophrenia
2. Genetic factors strongly shape how peers are chosen
3. Genetic analysis finds greater threat in frog-killing fungus
4. Genetic diversity in honeybee colonies boosts productivity
5. 2007-2008 Genzyme/ACMGF Clinical Genetics Fellowship In Biochemical Genetics award winner announced
6. Maynard Olson receives $500,000 Gruber Genetics Prize
7. Genetic defect links respiratory disease and congenital heart disease
8. Cell Press announces new partnership with the American Society of Human Genetics
9. Genetic fellow traveler discovered in Alzheimers
10. Health disparities -- Genetics, society and race play an important role in access to healthcare
11. Genetic studies endow mice with new color vision

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/25/2020)... ... ... Oxford Nanopore Technologies is in advanced development of a new generation of ... , The LamPORE assay is designed to be rapid, low cost, and scalable ... samples. Hardware and reagents sit outside current, squeezed supply chains for other molecular ...
(Date:5/21/2020)... ... May 20, 2020 , ... ... solutions for drugs, biologics, cell and gene therapies, and consumer health products, today ... Therapy, will be presenting at the ISCT 2020 Paris Virtual conference, which takes ...
(Date:5/15/2020)... ... May 15, 2020 , ... The National Institutes of Health (NIH) has ... in Frederick, Maryland and Tysons Corner, Virginia, to provide patent legal services under two ... in the field of chemistry. The firm is one of nine firms in the ...
Breaking Biology News(10 mins):
(Date:5/15/2020)... Mass. (PRWEB) , ... May 15, 2020 , ... Sentien ... the appointment of Richard Ganz as Executive Chairman. Mr. Ganz will continue to ... years, as well as work closely with CEO Brian Miller and Sentien’s management team. ...
(Date:5/14/2020)... ... May 12, 2020 , ... ... translational research, is bringing together thousands of industry leaders, clinicians, research scientists, medical ... two plenary speakers, Carl June, MD, Director of the Center for Cellular Immunotherapies ...
(Date:5/14/2020)... ... 13, 2020 , ... Early stages of drug discovery often ... information on the drug’s mechanism of action (MOA). Gene expression profiling technologies like ... activity of molecular pathways. This information can complement phenotypic readouts and can be ...
(Date:5/5/2020)... (PRWEB) , ... May 04, 2020 , ... ... process solutions for the life sciences industry, today announced that Informa Training Partners, ... officially changing its name to Red Nucleus Boston, effective immediately. , “The name ...
Breaking Biology Technology:
Cached News: